EWTX
Price
$14.70
Change
+$0.18 (+1.24%)
Updated
May 8 closing price
Capitalization
1.53B
90 days until earnings call
VERU
Price
$0.52
Change
+$0.02 (+4.00%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
76.43M
Earnings call today
Ad is loading...

EWTX vs VERU

Header iconEWTX vs VERU Comparison
Open Charts EWTX vs VERUBanner chart's image
Edgewise Therapeutics
Price$14.70
Change+$0.18 (+1.24%)
Volume$1.67M
Capitalization1.53B
Veru
Price$0.52
Change+$0.02 (+4.00%)
Volume$1.4K
Capitalization76.43M
EWTX vs VERU Comparison Chart
Loading...
EWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EWTX vs. VERU commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWTX is a Buy and VERU is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (EWTX: $14.70 vs. VERU: $0.52)
Brand notoriety: EWTX and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EWTX: 86% vs. VERU: 64%
Market capitalization -- EWTX: $1.53B vs. VERU: $76.43M
EWTX [@Biotechnology] is valued at $1.53B. VERU’s [@Biotechnology] market capitalization is $76.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EWTX’s FA Score shows that 1 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • EWTX’s FA Score: 1 green, 4 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, EWTX is a better buy in the long-term than VERU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EWTX’s TA Score shows that 4 TA indicator(s) are bullish while VERU’s TA Score has 2 bullish TA indicator(s).

  • EWTX’s TA Score: 4 bullish, 4 bearish.
  • VERU’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, EWTX is a better buy in the short-term than VERU.

Price Growth

EWTX (@Biotechnology) experienced а -11.87% price change this week, while VERU (@Biotechnology) price change was -0.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

EWTX is expected to report earnings on Aug 07, 2025.

VERU is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EWTX($1.53B) has a higher market cap than VERU($76.4M). VERU YTD gains are higher at: -22.936 vs. EWTX (-44.944). VERU has higher annual earnings (EBITDA): -38.84M vs. EWTX (-156.54M). EWTX has more cash in the bank: 470M vs. VERU (26.6M). VERU has less debt than EWTX: VERU (3.52M) vs EWTX (4.74M). VERU has higher revenues than EWTX: VERU (16.9M) vs EWTX (0).
EWTXVERUEWTX / VERU
Capitalization1.53B76.4M1,999%
EBITDA-156.54M-38.84M403%
Gain YTD-44.944-22.936196%
P/E RatioN/AN/A-
Revenue016.9M-
Total Cash470M26.6M1,767%
Total Debt4.74M3.52M135%
FUNDAMENTALS RATINGS
VERU: Fundamental Ratings
VERU
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EWTXVERU
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 16 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
EWTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
UOPSX66.17N/A
N/A
ProFunds UltraNASDAQ-100 Svc
QGRPX16.41N/A
N/A
UBS US Quality Growth At Rsnbl Prc P
GTCAX22.43N/A
N/A
Gabelli Global Content & Connect A
FSRPX18.28N/A
N/A
Fidelity Select Retailing
VTCLX289.92N/A
N/A
Vanguard Tax-Managed Capital App Adm

EWTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EWTX has been loosely correlated with ACHL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EWTX jumps, then ACHL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EWTX
1D Price
Change %
EWTX100%
+1.24%
ACHL - EWTX
33%
Loosely correlated
N/A
ATXS - EWTX
33%
Loosely correlated
-0.45%
VIR - EWTX
33%
Loosely correlated
-3.57%
AXON - EWTX
33%
Loosely correlated
+14.13%
KYMR - EWTX
33%
Loosely correlated
+5.70%
More

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with ALLK. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then ALLK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
-0.16%
ALLK - VERU
51%
Loosely correlated
N/A
PXXLF - VERU
37%
Loosely correlated
N/A
PRAX - VERU
35%
Loosely correlated
+8.30%
QLGN - VERU
34%
Loosely correlated
+3.19%
SRRK - VERU
32%
Poorly correlated
+1.33%
More